References
- Weisberg SP, McCann D and Delai Met al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003;112:1796–808
- Bastard JP, Maachi M and Van Nhieu JTet al. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab 2002;87:2084–9
- Chirico V, Lacquaniti A and Salpietro Vet al. High-mobility group box 1 (HMGB1) in childhood: from bench to bedside. Eur J Pediatr 2014;173:1123–36
- Wang BO, Koga K and Osuga Yet al. High mobility group box 1 (HMGB1) levels in the placenta and in serum in preeclampsia. Am J Reprod Immunol 2011;66:143–8
- Nativel B, Marimotou M and Thon-Hon VGet al. Soluble HMGB1 is a novel adipokine stimulating IL-6 secretion through RAGE receptor in SW872 preadipocyte cell line: contribution to chronic inflammation in fat tissue. PLoS One 2013;8:e76039
- Goodwin GH, Brown E and Walker JMet al. The isolation of three new high mobility group nuclear proteins. Biochim Biophys Acta 1980;623:329–38
- Fukami A, Adachi H and Yamagishi Set al. Factors associated with serum high mobility group box 1 (HMGB1) levels in a general population. Metab Clin Exp 2009;58:1688–93
- Dumitriu IE, Baruah P and Manfredi AA. HMGB1: guiding immunity from within. Trend Immunol 2005;26:381–7
- Bonaldi T, Talamo F and Scaffidi P. Monocyte cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J 2003;22:5551–60
- Lappalainen T, Kolehmainen M and Schwab Uet al. Gene expression of FTO in human subcutaneous adipose tissue peripheral blood mononuclear cells and adipocyte cell line. J Nutrigenet Nutrigenomics 2010;3:37–45
- Arrigo T, Chirico V and Salpietro V. Hig-mobility group protein B1: a new biomarker of metabolic syndrome in obese children. Eur J Endocrinol 2013;168:631–8
- Briley AL, Barr S and Badger Set al. A complex intervention to improve pregnancy outcome in obese women; the UPBEAT randomised controlled trial. BMC Pregnan Childbir 2014;14:74
- Tsoi E, Shaikh H, Robinson S and Teoh TG. Obesity in pregnancy: a major healthcare issue. Postgrad Med J 2010;86:617–23
- Poston L, Harthoorn LF and van der Beek EM; Contributors to the ILSI Europe Workshop. Obesity in pregnancy: implications for the mother and lifelong health of the child. A consensus statement. Pediatr Res 2011;69:175–80
- Ohmori H, Luo Y and Kuniyasu H. HMGB1 as a therapeutic target in colonrectal cancer. Expert Opin Ther Targets 2011;15:183–93
- Liu Y, Prasad R and Wilson SH. HMGB1: roles in base excision repair and related function. Biochim Biophys Acta 2010;10:119–30
- Chen YD, Golay A, Swislocki ALM and Reaven GM. Resistance to insulin suppression of plasma free fatty acid concentrations and insulin stimulation of glucose uptake in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1987;64:17–21
- Hedderson MM and Gunderson EP. Gestational weight gain and risk of gestational diabetes mellitus. Obstet Gynecol 2010;115:597–604